Table 2.

Comparison of groups after propensity matching

Variable	Values	PFC (n = 359)	RSCL (n = 101)	P value
Age in years	Median [Q1-Q3]	64 [ 55.8–73]	64 [ 57–73.3]	0.818
Sex, n (%)	Female	50 (54.3)	56 (60.9)	0.470
	Male	42 (45.7)	36 (39.1)
Race (White), n (%)	Yes	76 (82.6)	80 (87)	0.540
Origin of patient, n (%)	From acute care hospital inpatient	11 (12)	9 (9.8)	< 0.001
	Not transferred (admitted from home)	58 (63)	54 (58.7)
	Nursing home–chronic care–intermediate care	4 (4.3)	4 (4.3)
	Outside emergency department	18 (19.6)	22 (23.9)
	Transfer from other	1 (1.1)	3 (3.3)
Septic shock, n (%)	Yes	31 (33.7)	31 (33.7)	> 0.99
Ventilator dependent prior to surgery	Yes	6 (6.5)	5 (5.4)	> 0.99
Comorbidities, n (%)
Diabetes	Insulin	5 (5.4)	5 (5.4)	0.414
	No	78 (84.8)	80 (87)
	Non-insulin	9 (9.8)	7 (7.6)
Smoking	Yes	17 (18.5)	20 (21.7)	0.677
COPD	Yes	12 (13)	12 (13)	> 0.99
Ascites	Yes	1 (1.1)	2 (2.2)	> 0.99
CHF	Yes	6 (6.5)	3 (3.3)	0.505
Hypertension requiring medication	Yes	52 (56.5)	51 (55.4)	> 0.99
Renal failure	Yes	3 (3.3)	5 (5.4)	0.724
Dialysis	Yes	2 (2.2)	3 (3.3)	> 0.99
Disseminated cancer	Yes	7 (7.6)	8 (8.7)	> 0.99
Steroid use	Yes	26 (28.3)	20 (21.7)	0.377
Weight loss	Yes	5 (5.4)	3 (3.3)	0.724
Bleeding disorder	Yes	13 (14.1)	15 (16.3)	0.838
Transfusion requirement, n (%)	Yes	2 (2.2)	3 (3.3)	> 0.99
ASA class, n (%)	1-No disturb	0 (0)	0 (0)	0.442
	2-Mild disturb	14 (15.2)	15 (16.3)
	3-Severe disturb	39 (42.4)	35 (38)
	4-Life threat	33 (35.9)	39 (42.4)
	5-Moribund	6 (6.5)	3 (3.3)
	None assigned	0 (0)	0 (0)

COPD Chronic obstructive pulmonary disease, CHF congestive heart failure, ASA class American Society of anesthesiologist classification, Q1–Q3 interquartile range between 1st and 3rd quartile